Our results indicate that KYN, as an immunosuppressant, was most effective and enhanced the immune responses to the T1D GAD65 phage vaccine by inducing regulatory T cells and antigen-specific tolerance. The gene discussed is GAD2; the disease is type 1 diabetes mellitus.